The present study explored the immune implication of TMEM119 in STAD, and revealed that elevated TMEM119 expression in STAD correlates with poor patient prognosis and is closely linked to the tumour microenvironment. This evidence concerns the gene TMEM119 and gastric adenocarcinoma.